AMAG Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. Its products include Makena and Feraheme. It focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It also manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. The company was founded on November 9, 1981 and is headquartered in Waltham, MA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
What is Market Cap of AMAG Pharmaceuticals Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. AMAG Pharmaceuticals Inc market cap is $477.47M.
What is the 52-week high for AMAG Pharmaceuticals Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. AMAG Pharmaceuticals Inc 52 week high is $13.80 as of September 15, 2025.
What is the 52-week low for AMAG Pharmaceuticals Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. AMAG Pharmaceuticals Inc 52 week low is $4.41 as of September 15, 2025.
What was AMAG Pharmaceuticals Inc stock price yesterday?
AMAG Pharmaceuticals Inc stock price yesterday was $13.75.
What is the PE ratio of AMAG Pharmaceuticals Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. AMAG Pharmaceuticals Inc’s P/E ratio is -2.04.
What is the Price-to-Book ratio of AMAG Pharmaceuticals Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. AMAG Pharmaceuticals Inc P/B ratio is 1.8531.
What is the 50-day moving average of AMAG Pharmaceuticals Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. AMAG Pharmaceuticals Inc 50-day moving average is $12.24.